Sign in Subscribe

Enforcement Tracker

A curated record of FTC actions, class action settlements, state AG complaints, and NAD decisions involving consumer product claims. Focused on home goods, bedding, kitchen, personal care, and health products.

Regulatory Actions, Lawsuits, and Settlements in Consumer Products

When brands make false claims about their products, enforcement sometimes follows, through FTC actions, state attorney general complaints, NAD decisions, and class action lawsuits. But these outcomes are scattered across government databases, legal news sites, and court records. Unless you're actively looking, you'd never know they happened.

This page collects enforcement actions specifically involving the kinds of claims Material Truths investigates: false material and technology claims, deceptive pricing, fabricated certifications, misleading origin claims, and unsubstantiated health claims in physical consumer products.

We update this tracker as new actions are filed, settled, or decided. Each entry connects to the deception pattern it represents.

Jump to category

How to Read This Tracker

Each entry includes: the brand, the claim type, the enforcement body, the outcome, and which deception pattern it maps to. We link to the primary source (FTC press release, court filing, or settlement website) so you can verify every entry yourself.

Status key:

  • Settled: Case resolved, penalties or changes agreed to
  • Active: Case currently in litigation or under investigation
  • Consent Decree: Brand agreed to stop specific practices under regulatory order
  • NAD Decision: National Advertising Division recommended changes (industry self-regulation)

Bedding & Sleep Products

MyPillow: Unsubstantiated Health Claims

  • Year: 2017
  • Enforcement: California Attorney General (10 counties)
  • Claim type: Advertised pillow could cure insomnia, sleep apnea, fibromyalgia, and other conditions without clinical evidence
  • Outcome: Settled for ~$1 million. Company required to remove unsubstantiated health claims.
  • Status: Settled
  • Deception pattern: Sciencewashing | Health outcome claims without clinical substantiation
  • Initiated by: Truth in Advertising (TINA.org) complaint
  • Source: TINA.org investigation | NBC News coverage

MyPillow: Deceptive Pricing (2026)

  • Year: 2026
  • Enforcement: California federal court (class action)
  • Claim type: Permanent "sale" prices with fictitious reference prices; hidden fees not included in advertised prices
  • Outcome: Active litigation
  • Status: Active
  • Deception pattern: Deceptive pricing
  • Source: Top Class Actions | TINA.org

Moonlight Slumber: Fabricated Certifications and Health Claims

  • Year: 2017
  • Enforcement: FTC
  • Claim type: Made unsupported claims about baby mattresses being organic, natural, and plant-based. Created its own "Green Safety Shield" certification and awarded it to its own products.
  • Outcome: Consent decree. Barred from making misleading health and environmental claims. Barred from misrepresenting test results or claiming benefits are scientifically proven.
  • Status: Consent Decree
  • Deception pattern: Credential Inflation | Self-granted certifications
  • Source: FTC press release | FTC case page

Essentia / Ecobaby / Relief-Mart: False Material Claims

  • Year: 2013
  • Enforcement: FTC
  • Claim type: Three mattress companies claimed products were free of VOCs, chemical-free, and odor-free without scientific evidence. Essentia also claimed mattresses were 100% natural materials.
  • Outcome: All three companies barred from making unsupported claims. Required to have competent scientific evidence for future claims.
  • Status: Consent Decree
  • Deception pattern: Sciencewashing | Unsubstantiated material claims
  • Source: FTC press release | FTC final consent order

Resident Home / DreamCloud: False Origin Claims

Sealy / American Textile: False Thread Count Claims

Mattress Firm: Deceptive Pricing

  • Year: 2025
  • Enforcement: Class action (California)
  • Claim type: Fictitious "strikethrough" original prices on website to create illusion of discounts. Products never sold at the claimed regular price.
  • Outcome: $6.4 million settlement.
  • Status: Settled
  • Deception pattern: Deceptive pricing
  • Source: ClassAction.org — settlement | ClassAction.org — original lawsuit

↑ Back to top

Supplements & Health Products

Prevagen (Quincy Bioscience): Unsubstantiated Memory Claims

  • Year: 2017-2024
  • Enforcement: FTC + New York Attorney General (joint action); class action settlement; federal jury trial
  • Claim type: Marketed Prevagen as "clinically shown" to improve memory and provide cognitive benefits. The company's own clinical study (Madison Memory Study) failed to show statistically significant improvement over placebo on any of the nine cognitive tasks tested. Company performed post hoc analysis of data subgroups to manufacture positive findings after the full study failed.
  • Outcome: $2.5 million class action settlement (2020). In 2024, a federal jury found Quincy Bioscience liable for false advertising on all eight challenged marketing claims. Court ordered the company to cease making unsubstantiated memory improvement claims. Prevagen generated over $165 million in U.S. sales during the period in question.
  • Status: Settled (class action); Active (ongoing federal litigation)
  • Deception pattern: Sciencewashing | Unsubstantiated health claims; cherry-picked clinical data
  • Initiated by: FTC + NY Attorney General joint complaint
  • Source: FTC case page

Thesis Nootropics (Outliers, Inc.): Implied Drug Claims

  • Year: 2025
  • Enforcement: Class action (S.D.N.Y., Case 1:25-cv-10790)
  • Claim type: Marketed nootropic supplement as a substitute for Adderall, a prescription medication. Ad headline "Goodbye Adderall" positions a dietary supplement as a replacement for a controlled substance, which under 21 U.S.C. 321(g)(1)(B) makes the product an unapproved drug.
  • Outcome: Active litigation
  • Status: Active
  • Deception pattern: Sciencewashing | Implied drug claims for dietary supplements
  • Source: PacerMonitor | Justia docket

Thesis Nootropics (Outliers, Inc.): Undisclosed Amphetamines

  • Year: 2024
  • Enforcement: Federal lawsuit (W.D. Wash., Case 3:24-cv-05808)
  • Claim type: Plaintiff, a military hospital nurse, purchased Thesis supplements marketed as a "safe, all-natural, better alternative" to prescription stimulants. After taking the supplements for approximately six months, she tested positive for amphetamines during a routine military drug screening. Lawsuit alleges the supplements contained undisclosed amphetamines and other ingredients not listed on the label, despite being marketed as a natural alternative to amphetamine-based medications.
  • Outcome: Active litigation
  • Status: Active
  • Deception pattern: Undisclosed ingredients | False material claims
  • Source: Justia | Court order denying motion to dismiss

Rytr LLC: AI-Generated Fake Reviews

  • Year: 2024 (consent order); 2025 (order vacated)
  • Enforcement: FTC (Operation AI Comply)
  • Claim type: Sold an AI writing assistant service that allowed subscribers to generate unlimited fake consumer reviews. At least one subscriber generated over 83,000 reviews for various businesses. FTC alleged the service provided the "means and instrumentalities" for deceptive practices and would "pollute the marketplace with a glut of fake reviews."
  • Outcome: Original consent order (December 2024) banned Rytr from offering any AI service generating consumer reviews. Order was vacated in December 2025 under the Trump Administration's AI Action Plan, with the FTC concluding the original complaint failed to adequately allege a violation and the remedy unduly burdened AI innovation.
  • Status: Order Vacated
  • Deception pattern: Fake reviews | AI-enabled deception at scale
  • Source: FTC final order (2024) | FTC order vacated (2025)

Note: The Rytr entry illustrates an important pattern in enforcement: regulatory outcomes can be reversed. The original FTC action against Rytr was vacated under a new administration's policy priorities, despite the underlying facts being undisputed. Material Truths tracks these reversals because enforcement is not the same as resolution. A vacated order does not mean the conduct was acceptable; it means the enforcement environment changed.

↑ Back to top

Personal Care & Beauty

Sunday Riley Skincare: Employee-Written Fake Reviews

  • Year: 2019 (complaint); 2020 (final consent order)
  • Enforcement: FTC
  • Claim type: CEO Sunday Riley and company managers posted fake five-star reviews of their own products on Sephora.com using fake accounts for nearly two years (November 2015 to August 2017). When Sephora detected and removed the fake reviews, the company obtained a VPN to hide employee IP addresses and continued posting. CEO emailed step-by-step instructions to staff for creating fake personas, directed employees to "always leave 5 stars," and instructed them to "dislike" negative reviews to trigger removal. Interns were also directed to create fake accounts and write reviews.
  • Outcome: Consent decree. Prohibited from misrepresenting reviewer identities. Required to disclose material connections between endorsers and the company. No monetary penalty, no disgorgement of profits, no admission of wrongdoing. Each future violation subject to civil penalties up to $42,530.
  • Status: Consent Decree
  • Deception pattern: Fake reviews | Systematic corporate review fraud
  • Initiated by: Whistleblower (former employee posted evidence on Reddit, October 2018)
  • Source: FTC press release | FTC final consent agreement

↑ Back to top

Cookware & Kitchen

Entries coming as investigations in this category are published. Know of an enforcement action we should include? Email us at investigations@materialtruths.com.

↑ Back to top

Home Products

Entries coming as investigations in this category are published.

↑ Back to top

How We Source This Information

We monitor enforcement actions from: the Federal Trade Commission (ftc.gov), state attorneys general offices, the National Advertising Division (NAD), Truth in Advertising (TINA.org), ClassAction.org, and federal/state court filings. We focus specifically on actions involving physical consumer products and the claim types Material Truths investigates.

This tracker is not comprehensive. It's curated. We include actions that are relevant to the deception patterns we've documented, that involve product categories we cover, and that provide useful precedent for consumers evaluating similar claims from other brands.

If you know of an enforcement action involving false product claims that should be on this tracker, email us at investigations@materialtruths.com.